EWY vs IBB
iShares MSCI South Korea ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.59% for EWY.
- • EWY pays a higher dividend yield (1.29%).
Side-by-side metrics
| Metric | EWY | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.29% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $21.05B | $7.95B |
YTD return | 87.18% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.13 | 0.74 |
P/E ratio | 23.20 | 23.72 |
Last price | $176.75 | $170.10 |
Inception | — | — |
Issuer | iShares | iShares |
EWY top holdings
| 000660.KS | SK Hynix Inc | 22.69% |
| 005930.KS | Samsung Electronics Co Ltd | 22.34% |
| 402340.KS | SK Square | 2.78% |
| 005380.KS | Hyundai Motor Co | 2.40% |
| 105560.KS | KB Financial Group Inc | 1.99% |
| 034020.KS | Doosan Enerbility Co Ltd | 1.95% |
| 009150.KS | Samsung Electro-Mechanics Co Ltd | 1.79% |
| 012450.KS | Hanwha Aerospace Co Ltd | 1.64% |
| 006400.KS | Samsung SDI Co Ltd | 1.54% |
| 055550.KS | Shinhan Financial Group Co Ltd | 1.48% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About EWY
EWY (iShares MSCI South Korea ETF) is South Korean large and mid-cap equities. Managed by iShares, the fund carries $21.0B in assets under management, an expense ratio of 0.59%, a dividend yield of 1.29%. Its largest holding is SK Hynix Inc (000660.KS), which represents 22.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.7%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.